DiagnaMed Expects Brain Health AI Platform To Be Commercialized In Q4 2023
DiagnaMed Holdings (CSE: DMED) is anticipating to begin the commercialization stage of its flagship CERVAI brain health AI platform in the fourth quarter of 2023.
Read more
Biotech
Denmark’s GDP Gets A Big Boost From Ozempic
National statistics data show that Denmark’s GDP experienced a surge of 1.7% year-on-year during the first half of this year.
Read more
California Senate Votes to Decriminalize Psychedelics
California lawmakers have passed Senate Bill 58, a groundbreaking piece of legislation that decriminalizes the possession and personal use of
Read more
Did AI Just Make It Easier To Make Chemical Weapons?
A team of scientists has warned that artificial intelligence (AI) could be used to design new biochemical weapons. The researchers,
Read more
Early Study Shows New Cancer-Killing Pill Can Target and Eliminate All Types of Solid Tumors
Scientists have unveiled a groundbreaking cancer-fighting pill that has the potential to revolutionize cancer treatment. The molecule, named AOH1996 after
Read more
Elizabeth Holmes Quietly Gets Two Years Off Her Sentence
Disgraced Theranos founder Elizabeth Holmes is set to have her prison sentence shortened by approximately two years, according to federal
Read more
Former Pfizer Employee Charged by SEC for Insider Trading
Former Pfizer Inc. (NYSE: PFE) employee Amit Dagar and his close friend and business partner, Atul Bhiwapurkar, are facing insider
Read more
From Lab to Table: Cultivated Chicken Meat Approved for US Sale
US regulators have granted approval for the sale of lab-grown chicken made from animal cells, marking a significant milestone for
Read more
DiagnaMed Anticipates CERVAI Commercial Launch In Q4 2023
DiagnaMed Holdings (CSE: DMED) is expected to begin the deployment of its brain age estimation tool known as CERVAI to third party sites in the fourth quarter of 2023.
Read more
DiagnaMed Launches Dr. GenAI, A Generative AI Medical Chatbot
DiagnaMed Holdings (CSE: DMED) has launched its third generative AI product to the marketplace.
Read more